Log In
Print
BCIQ
Print
Print this Print this
 

AMP-514

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionMAb against PD-1 receptor (PDCD1; PD-1; CD279)
Molecular Target Programmed cell death 1 (PDCD1) (PD-1) (CD279)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today